Key result
Serotonin receptor antagonism improves survival after MI and sepsis in animal models.
Answers are grounded in this paper and cite their sources.
This short review addresses immune functions of platelet serotonin. Platelets transport serotonin at a high concentration in dense granules and release it upon activation. Besides haemostatic, vasotonic and developmental modulation, serotonin also influences a variety of immune functions (mediated by different serotonin receptors). First, platelet serotonergic effects are directed against invading pathogens via activation and proliferation of lymphocytes, modulation of cytokine release, and recruitment of neutrophils to sites of acute inflammation by induction of selectin expression on endothelial cells. Second, serotonin levels are elevated in autoimmune diseases, such as asthma or rheumatoid arthritis, and during tissue regeneration after ischemia of myocardium or brain. Specific antagonism of serotonin receptors appears to improve survival after myocardial infarction or sepsis and to attenuate asthmatic attacks in animal models. It will be of great clinical relevance if these findings can be translated into human applications. In conclusion, targeting immune modulatory effects of platelet serotonin may provide novel therapeutic options for common health problems.
No takes yet. Share an insight, caveat, or question.
Mauler et al. (2015) conducted a review in Autoimmune diseases, acute inflammation, sepsis, and myocardial or brain ischemia. Platelet serotonin / serotonin receptor antagonism was evaluated. Platelet serotonin modulates immune responses, and specific serotonin receptor antagonism improves survival after myocardial infarction or sepsis in animal models.
Synapse has enriched 10 related papers. Consider them for comparative context: